论文部分内容阅读
本文报告55例卵巢良性、恶性肿瘤,非卵巢恶性肿瘤及正常妇女的血清癌抗原(CA_(125))和癌胚抗原(CEA)的测定结果:以CA_(125)<65U/ml,CEA<20ng/ml为正常值。14例正常妇女CA_(125)及CEA值均正常。20例卵巢恶性肿瘤中CA_(125)阳性率为60％(12/20),CEA阳性率为25％(5/20);5例非卵巢恶性肿瘤中CA_(125)阳性率为20％(1/5),CEA阳性率为80％(4/5);16例卵巢良性肿瘤中CA_(125)阳性率6％(1/16),CEA阳性率为19％(3/16)。结果表明CA_(125)在卵巢恶性肿瘤中阳性率高(X~2=5.01 P<0.05);CEA在非卵巢恶性肿瘤中阳性率高(X~2=5.25 P<0.05);在卵巢良性肿瘤中二者无差异(X~2=1.14 P>0.250)。
In this paper, 55 cases of benign and malignant ovarian tumors, non-ovarian cancer and normal women’s serum cancer antigen (CA_ (125)) and carcinoembryonic antigen (CEA) determination results: CA_ (125) <65U / ml, CEA < 20ng / ml for the normal value. 14 normal women CA_ (125) and CEA values were normal. The positive rate of CA 125 was 60% (12/20) in 20 cases of ovarian malignant tumors and the positive rate of CEA was 25% (5/20). The positive rate of CA 125 in 5 cases of non-ovarian malignant tumors was 20% 1/5). The positive rate of CEA was 80% (4/5). The positive rate of CA 125 was 16% (1/16) in 16 cases of ovarian benign tumors and 19% (3/16) in CEA. The results showed that the positive rate of CA 125 in ovary malignant tumors was high (X 2 = 5.01 P <0.05). The positive rate of CEA in non-ovarian malignant tumors was high (X 2 = 5.25 P <0.05) There was no difference between the two (X ~ 2 = 1.14 P> 0.250).